EUDA Health Holdings Return on Tangible Equity 2022-2024 | EUDA
Current and historical return on tangible equity values for EUDA Health Holdings (EUDA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| EUDA Health Holdings Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.097B | $0.004B |
| EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.476B | 53.14 |
| Tempus AI (TEM) | United States | $9.826B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.069B | 145.79 |
| Inspire Medical Systems (INSP) | United States | $4.756B | 92.38 |
| IRhythm Technologies (IRTC) | United States | $4.186B | 0.00 |
| Privia Health (PRVA) | United States | $2.829B | 212.00 |
| Enovis (ENOV) | United States | $2.016B | 12.47 |
| Schrodinger (SDGR) | United States | $1.847B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.512B | 0.00 |
| Omnicell (OMCL) | United States | $1.460B | 31.48 |
| Azenta (AZTA) | United States | $1.232B | 57.36 |
| 10x Genomics (TXG) | United States | $1.031B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.634B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
| Talkspace (TALK) | United States | $0.537B | 319.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.456B | 0.00 |
| TruBridge (TBRG) | United States | $0.392B | 0.00 |
| Claritev (CTEV) | United States | $0.362B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.294B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.208B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.202B | 0.00 |
| Pulmonx (LUNG) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
| CareCloud (CCLD) | United States | $0.080B | 3.43 |
| 111 (YI) | China | $0.072B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |